Talaroconvolutin-A treated bladder cancer for proteomics sequencing

ABSTRACT: TalaA inhibits bladder cancer mainly through two approaches: 1) arresting cell cycle to suppress proliferation, 2) triggering ferroptosis to cause cell death. In molecular mechanism, TalaA can interact with MAPKs to repress the phosphorylation of transcription regulators. This study would open new avenues for bladder cancer treatment targeting MAPKs, inhibiting cell cycle and inducing ferroptosis.

ORGANISM(S): Homo Sapiens

SUBMITTER: Yong Xia  

PROVIDER: PXD037785 | iProX | Thu Oct 27 00:00:00 BST 2022

REPOSITORIES: iProX